Division of Nephrology, University of Toronto and Keenan Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada.
Curr Opin Nephrol Hypertens. 2011 Mar;20(2):182-8. doi: 10.1097/MNH.0b013e3283437046.
Conventional hemodialysis is often an incomplete treatment for uremia. People receiving hemodialysis often report a poor quality of life and suffer from an accelerated mortality rate. Nocturnal hemodialysis provides long treatments at night in the home or dialysis center. This review will examine how long nocturnal treatments have impact on the clearance of small and larger retention products, and how these treatments influence quality of life and survival.
Nocturnal hemodialysis is more effective at clearing most small and middle molecule retention products, and has been associated with improvements in quality of life, especially in those domains related to the effects of kidney disease. Survival on nocturnal hemodialysis is higher than expected, and studies suggest that patients receiving nocturnal hemodialysis have a mortality rate that is about one third of what is seen in similar patients receiving conventional hemodialysis.
Although impressive, it is difficult to be sure how much of the results of these studies is due to the duration and timing of dialysis and how much relates to patient level factors and residual confounding, and further research in this area is required.
常规血液透析治疗尿毒症往往不彻底。接受血液透析的患者常报告生活质量较差,死亡率加速。夜间血液透析可在夜间于家中或透析中心进行长时间治疗。本综述将探讨夜间治疗时间对小分子和大分子潴留物清除的影响,以及这些治疗如何影响生活质量和生存率。
夜间血液透析在清除大多数小分子和中分子潴留物方面更有效,并且与生活质量的改善相关,尤其是与肾脏病影响相关的领域。夜间血液透析的生存率高于预期,研究表明,接受夜间血液透析的患者死亡率约为接受常规血液透析的相似患者的三分之一。
尽管令人印象深刻,但很难确定这些研究结果中有多少归因于透析的持续时间和时间安排,以及有多少与患者个体因素和残余混杂因素有关,因此需要在该领域开展进一步的研究。